News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Invitrogen Corporation (IVGN) Strengthens DNA/RNA Purification Product Line With Acquisition Of DNA Research Innovations Ltd.


10/19/2005 5:11:58 PM

Invitrogen Corporation (Nasdaq:IVGN) today announced it has acquired DNA Research Innovations, Ltd. (DRI), a privately-held company based in Kent, England, that develops and markets innovative products for the purification of DNA and other nucleic acids. DRI's patent-protected ChargeSwitch(R) Technology (CST(R)) is versatile, works in multiple formats, produces high purity and yield, and is safe and easy-to-use. According to the terms of the deal, Invitrogen paid $35 million in cash, and may make contingent payments of up to $30 million based upon the completion of certain R & D milestones. The deal is not expected to change Invitrogen's guidance for the fourth quarter of 2004.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES